Target Healthcare REIT (LON:THRL) Reaches New 52-Week High – Time to Buy?

Target Healthcare REIT (LON:THRL)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as GBX 108.80 and last traded at GBX 108.60, with a volume of 1231975 shares trading hands. The stock had previously closed at GBX 108.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group restated a “hold” rating and issued a GBX 101 price target on shares of Target Healthcare REIT in a research note on Wednesday. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of GBX 101.

Target Healthcare REIT Stock Down 1.1%

The firm has a market cap of £667.38 million, a price-to-earnings ratio of 8.56, a price-to-earnings-growth ratio of 1.48 and a beta of 0.69. The stock’s 50 day moving average is GBX 103.35 and its 200 day moving average is GBX 100.63.

Target Healthcare REIT (LON:THRL) last posted its quarterly earnings data on Wednesday, March 18th. The company reported GBX 3.38 EPS for the quarter. Target Healthcare REIT had a net margin of 104.45% and a return on equity of 10.73%. Analysts anticipate that Target Healthcare REIT will post 6.2219101 earnings per share for the current fiscal year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.